Items where Author is "Makvandi, P."

(2026) Antioxidant and antimicrobial design of bio-derived nanoarchitectures for regenerative medicine. Coordination Chemistry Reviews. p. 27. ISSN 0010-8545

(2026) Iron-doped carbon-based nanoparticles: emerging strategies in cancer therapeutics. Advanced Composites and Hybrid Materials. p. 23. ISSN 2522-0128

(2026) Resensitizing drug-resistant cancers by co-targeting apoptosis and mitochondrial stress pathway. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. p. 101443. ISSN 1532-2084 (Electronic) 1368-7646 (Linking)

(2026) The interplay between autophagy and immunogenic cell death: nanomaterial-based strategies for cancer immunotherapy. Journal of Nanobiotechnology. p. 37.

(2025) Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology-based strategies for enhanced CAR T/NK cell therapy. Bioengineering & translational medicine. e10716. ISSN 2380-6761 (Print) 2380-6761 (Electronic) 2380-6761 (Linking)

(2025) Smart Mesoporous Silica Nanoparticles in Cancer: Diagnosis, Treatment, Immunogenicity, and Clinical Translation. Small. p. 32. ISSN 1613-6810

(2025) Stimuli-responsive smart nanomaterials for theranostics of urological cancers. Coordination Chemistry Reviews. p. 22. ISSN 0010-8545

(2025) The role of curcumin in modulating circular RNAs and long non-coding RNAs in cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. pp. 2416-2436. ISSN 1699-3055 (Electronic) 1699-048X (Linking)

(2024) Exploring metal-organic frameworks in gene delivery: From prostate to lung therapeutics. Applied Materials Today. p. 19. ISSN 2352-9407

(2024) The role of curcumin in modulating circular RNAs and long non-coding RNAs in cancer. Clinical & Translational Oncology. p. 21. ISSN 1699-048X

(2023) Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering. Environmental Research. p. 18. ISSN 0013-9351

(2023) Microfluidic platforms in diagnostic of ovarian cancer. Environmental Research. p. 17. ISSN 0013-9351

(2023) Microfluidic-based technologies in cancer liquid biopsy: Unveiling the role of horizontal gene transfer (HGT) materials. Environmental Research. p. 12. ISSN 0013-9351

(2023) Unmasking the complex roles of hypocalcemia in cancer, COVID-19, and sepsis: Engineered nanodelivery and diagnosis. Environmental Research. p. 15. ISSN 0013-9351

(2023) Unraveling the potential of M13 phages in biomedicine: Advancing drug nanodelivery and gene therapy. Environmental Research. p. 20. ISSN 0013-9351

(2023) miRNA-encapsulated abiotic materials and biovectors for cutaneous and oral wound healing: Biogenesis, mechanisms, and delivery nanocarriers. Bioengineering & translational medicine. e10343. ISSN 2380-6761 (Print) 2380-6761 (Electronic) 2380-6761 (Linking)

(2023) The molecular perspective on the melanoma and genome engineering of T-cells in targeting therapy. Environmental Research. p. 17. ISSN 0013-9351

(2022) Antibacterial Host-Guest Intercalated LDH-Adorned Polyurethane for Accelerated Dermal Wound Healing. ACS applied bio materials. pp. 5800-5815. ISSN 2576-6422

(2022) Dendrimers as nanoscale vectors: Unlocking the bars of cancer therapy. Semin Cancer Biol. ISSN 1044-579x

(2022) Genetically Engineered Viral Vectors and Organic-Based Non-Viral Nanocarriers for Drug Delivery Applications. Advanced Healthcare Materials. p. 31. ISSN 2192-2640

(2022) Genetically Engineered Viral Vectors and Organic-Based Non-Viral Nanocarriers for Drug Delivery Applications. Adv Healthc Mater. e2201583. ISSN 2192-2640

(2022) Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli-Responsive, Toxicity, Immunogenicity, and Clinical Translation. Adv Sci (Weinh). e2102678. ISSN 2198-3844

(2022) pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer. ACS APPLIED BIO MATERIALS. pp. 675-690. ISSN 2576-6422 J9 - ACS APPL BIO MATER

(2022) pH-Responsive, Adorned Nanoniosomes for Codelivery of Cisplatin and Epirubicin: Synergistic Treatment of Breast Cancer. ACS applied bio materials. pp. 675-690. ISSN 2576-6422 (Electronic) 2576-6422 (Linking)

(2021) The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy. International Journal of Molecular Sciences.

(2021) Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside. Acs Biomaterials Science & Engineering. pp. 2150-2176. ISSN 2373-9878